Cas no for 1194-02-1,4-fluorobenzonitrile ACID Cas number search msds database,online free cas number chemistry search engine,cas number sigma aldrich - PharmaSources.com

Products
Suppliers
Sourcing Requests

Post Sourcing Request Exhibition

Home
Products
Supplier
E-Trade Season
Content Hub
Industry Insights
Service & Membership
For Supplier

My Account

My Online Store

My EZSourcing

View Sourcing Requests

Customer Service
For Buyer

Search Products & Suppliers
Products Directory Suppliers Discovery Post EZSourcing
Service
Buyer Sourcing Event Contact Us
Quick links
My Favorites Recent Visit History

Home > CAS No. Inquiry > 1194-02-1

1194-02-1

[CAS Name] 4-fluorobenzonitrile

[Formula] C7H4FN

Search Products Post Sourcing Request

Basica Info

[CAS Name]4-fluorobenzonitrile
[Alias]p-Fluorobenzonitrile; PFBN; 4-fluoro-benzonitril; Benzonitrile, p-fluoro-; p-Cyanofluorobenzene; p-fluoro-benzonitril; P-Fluorobenzonitile
[Number]1194-02-1
[EINECS]214-784-9
[Formula]C7H4FN
[Molecular weight]121.1118

[Melting point]33-36℃
[Boiling point]189.6°C at 760 mmHg
[Density]0.564mmHg at 25°C
[Flash point]65.6°C

1194-02-1 Suppliers

Company

Main Products

Shenzhen Excellent Biomedical Technology Co., Ltd.	Shenzhen Excellent Biomedical Technology Co.,Ltd.(SZEB) is a leading supplier of high quality pharmaceutical impurities,API related compounds,intermediates,labeled standards and impurity custom synthesis services.E-mail:sales@ex-biotech.com. Discover all our products through our official website (https://www.ex-biotech.com/), and get in touch if you have any questions about how we can help support your work. Email:sale@ex-biotech.com.	Send Inquiry
Nanyang Junhao Chemical Co., LTD	Factory Location:Henan	Send Inquiry
Chongqing Xingcan Pharmaceutical Technology Co., Ltd	p-fluorobenzonitrile, also known as 4-fluorobenzonitrile, is a pharmaceutical intermediate that can be used in the preparation of afatinib. Afatinib maleate was approved in the United States in 2013 for the treatment of metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 (L858R) replacement mutation.	Send Inquiry

Previous page 1 2 3 Next page

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

About Us: About PharmaSources; Terms of Service; Privacy Policy; Event Data Sharing Notice; Intellectual Property; Media Partners

Buy: Search Products; Post Sourcing Requests; Search Suppliers; CAS Search

Sell: Member Application; Advertising; Post Products; EZSourcing

Events: CPHI China; PMEC China; Conferences; Search Events

Help: FAQ; Contact Us; Feedback

Copyright 2006-2025 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182 沪公网安备31010402010101号
Links：
CCCMHPIE SJGLE.com JJGLE.COM JDGLE.COM XIUGLE.COM DENGGLE.COM HPGLE.COM
Follow Us：
Pharma Sources Insight July 2025

PharmaSources Customer Service